PhysioSign, Inc. USA

PhysioSign USA is a pioneering company specializing in advanced surface electrocardiography (ECG) integrated with non-invasive electrophysiology (EP). Our breakthrough technology enables comprehensive scanning and recording of all electrophysiological signals on the human body surface, including the sinoatrial node (SAN), atria, atrioventricular node (AVN), His bundle, bundle branches, Purkinje fibers, endocardial and epicardial layers, M-cells, and wide QRS complexes. This innovation is protected by a U.S. patent. By combining surface ECG with artificial intelligence (AI), our technology captures both invasive and non-invasive electrophysiological parameters with unparalleled accuracy. The data obtained through this non-invasive method is comparable in precision to traditional invasive techniques. Key Innovations and Achievements: Real-Time Electrophysiological Mapping: Our technology enables natural, real-time scanning and recording of all electrophysiological markers directly from the human body surface, including the SAN, atria, AVN, His bundle, and Purkinje fibers. (U.S. Patent) Non-Invasive His Bundle Electrogram: We are the first in the world to achieve non-invasive recording of the His bundle electrogram. Digitized ECG Revolution: This marks the first digitized ECG advancement in 120 years, capturing all invasive and previously undetectable parameters. (U.S. Patent) AI-Driven Analysis: Our system leverages AI for precise reading and mapping, with measurements accurate to the millisecond. Early Abnormality Detection: The technology detects electrophysiological abnormalities, even in the absence of overt disease manifestations, such as atrioventricular nodal reentrant tachycardia (AVNRT), atrioventricular reentrant tachycardia (AVRT), supraventricular tachycardia (SVT), heart failure, coronary artery disease (CAD), and non-ST elevation myocardial infarction (MI). (U.S. Patent) Proprietary ECG Electrode: We have developed the world's first patented ECG ele

• Employees1
• Founded2005